Jeremy Bloomer

Jeremy Bloomer is on the Board of Directors of Neurovation Labs and is an advising member. Mr. Bloomer received his MBA in 1985 from The Amos Tuck School of Business Administration at Dartmouth College and a B.A. in 1980 from the University of Pennsylvania. He has over 20 years of investment banking, merchant banking, and investment management experience encompassing investment banking, research, sales, and trading in distressed securities, high yield securities, and private equity of emerging and middle market companies. He began his career in 1980 as a Commercial Loan Officer first at Chemical Bank and then Chase Manhattan Bank. Currently, Mr. Bloomer is the CEO and founder of the specialty finance company Greenwich Life Settlements, managing member of the Ivy Group, a NASD broker/dealer merchant bank he founded, and Vice Chairman of the Board of the New Fund Institute for Cancer Research. Previously, he was senior portfolio manager at the Airlie Group and co-founder of the boutique institutional investment bank Credit and Research & Trading, LLC (CRT).